All Acute coronary syndrome articles
-
SupplementImproving outcomes in the management of patients with chronic coronary syndrome and stable anginal chest pain for the acute and general physician
Information intended for UK healthcare professionals only.
This promotional supplement has been commissioned and funded by A. Menarini Farmaceutica Internazionale SRL and developed in partnership with Guidelines in Practice.
View Ranexa (ranolazine) prescribing information and adverse event reporting information here
PP-RA-UK-0627
Date of preparation: July 2021 -
Implementing guidelines
Cardiac arrhythmia: risk factors for heart disease need to be addressed
Dr Alan Begg summarises recommendations in SIGN’s latest guidance on cardiac arrhythmias that are relevant to primary care and highlights some major advances in treatment
-
Test and reflect
SIGN guideline on acute coronary syndrome
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on acute coronary syndrome (ACS)—you will then be prompted to reflect on your learning.
-
Implementing guidelines
SIGN updates guidance on diagnosis and management of ACS
Dr Alan Begg summarises SIGN recommendations for the immediate assessment, management, and discharge arrangements for people with acute coronary syndrome
-
Personal view
Hyperglycaemia should be managed in patients with ACS
Dr Alan Begg highlights points for primary care relating to the NICE guideline on managing hyperglycaemia in acute coronary syndromes
-
Implementing guidelines
ACS and anginal chest pain require different diagnostic pathways
Dr Rajiv Rampat discusses the NICE guideline on the assessment of recent onset chest pain caused by suspected acute coronary syndrome or angina
